<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Prices of Imported Drugs</title>
    <link>https://www.taxtmi.com/news?id=3150</link>
    <description>NPPA observed price differentials between imported finished formulations and domestically produced equivalents supplied by foreign principals, and decided importers may be required to furnish details of the CIF price tied to their cost components to enable regulatory oversight of higher prices for imported formulations.</description>
    <language>en-us</language>
    <pubDate>Thu, 26 Apr 2012 18:09:43 +0530</pubDate>
    <lastBuildDate>Thu, 26 Apr 2012 18:09:43 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=305889" rel="self" type="application/rss+xml"/>
    <item>
      <title>Prices of Imported Drugs</title>
      <link>https://www.taxtmi.com/news?id=3150</link>
      <description>NPPA observed price differentials between imported finished formulations and domestically produced equivalents supplied by foreign principals, and decided importers may be required to furnish details of the CIF price tied to their cost components to enable regulatory oversight of higher prices for imported formulations.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Thu, 26 Apr 2012 18:09:43 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=3150</guid>
    </item>
  </channel>
</rss>